Patient-reported outcome measures for monitoring primary care patients with depression (PROMDEP): study protocol for a randomised controlled trial
Tony Kendrick(University of Southampton), Christopher Dowrick(University of Liverpool), Guiqing Yao(University of Leicester), Adam W A Geraghty(NIHR Southampton Biomedical Research Centre), Shihua Zhu(University of Southampton), Carl May(London School of Hygiene & Tropical Medicine), Samantha Williams, Michael Moore(Indiana University School of Medicine), Glyn Lewis(The London College), Rachel Dewar-Haggart(University of Southampton), Gareth Griffiths(NIHR Evaluation Trials and Studies Coordinating Centre), Beth Stuart(Queen Mary University of London), Geraldine Leydon(Broadmoor Hospital)
Cited by 13
Related Papers
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
|The Lancet|2007|570
MAIT cells are activated during human viral infections
|Nature Communications|2016|526
The epidemiology of fatigue: more questions than answers.
|Journal of Epidemiology & Community Health|1992|499